Literature DB >> 20641063

Origin of presacral local recurrence after rectal cancer treatment.

M Kusters1, C Wallner, M M Lange, M C DeRuiter, C J H van de Velde, Y Moriya, H J T Rutten.   

Abstract

BACKGROUND: The objective of this study was to obtain detailed anatomical information about the lateral lymph nodes, in order to determine whether they might play a role in presacral local recurrence of rectal cancer after total mesorectal excision without lateral lymph node dissection.
METHODS: Ten serially sectioned human fetal pelvises were studied at high magnification and a three-dimensional reconstruction of the fetal pelvis was made.
RESULTS: Examination of the histological sections and the three-dimensional reconstruction showed that lateral lymph node tissue comprises a major proportion of the pelvic tissue volume. There were no lymph nodes located in the presacral area. Connections between the mesorectal and extramesorectal lymph node system were found in all fetal pelvises, located below the peritoneal reflection on the anterolateral side of the fetal rectum. At this site middle rectal vessels passed to and from the mesorectum, and branches of the autonomic nervous system bridge to innervate the rectal wall.
CONCLUSION: The findings of this study support the hypothesis that tumour recurrence might arise from lateral lymph nodes.

Entities:  

Mesh:

Year:  2010        PMID: 20641063     DOI: 10.1002/bjs.7180

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  9 in total

1.  Clinical implication of additional selective lateral lymph node excision in patients with locally advanced rectal cancer who underwent preoperative chemoradiotherapy.

Authors:  Seok-Byung Lim; Chang Sik Yu; Chan Wook Kim; Yong Sik Yoon; Seong Ho Park; Tae Won Kim; Jong Hoon Kim; Jin Cheon Kim
Journal:  Int J Colorectal Dis       Date:  2013-08-14       Impact factor: 2.571

2.  Post-chemoradiation anastomotic recurrence in locally advanced rectal cancer: no increased risk associated with distal margin.

Authors:  F A Calvo; F Rivas; C V Sole; M Gómez-Espí; R Herranz; E Del Valle; M Rodríguez; E Alvarez
Journal:  Clin Transl Oncol       Date:  2013-10-16       Impact factor: 3.405

Review 3.  Risk factors for local recurrence following neoadjuvant chemoradiotherapy for rectal cancers.

Authors:  Jia-Yuan Peng; Zhong-Nan Li; Yu Wang
Journal:  World J Gastroenterol       Date:  2013-08-28       Impact factor: 5.742

4.  Treatment of lateral pelvic nodes metastases from rectal cancer: the future prospective.

Authors:  Y Moriya
Journal:  G Chir       Date:  2013 Sep-Oct

5.  Incidence and prognosis of lower rectal cancer with limited extramesorectal lymph node metastasis.

Authors:  Shin Fujita
Journal:  Int J Colorectal Dis       Date:  2014-06-29       Impact factor: 2.571

Review 6.  Neo-adjuvant radiotherapy in rectal cancer.

Authors:  Bengt Glimelius
Journal:  World J Gastroenterol       Date:  2013-12-14       Impact factor: 5.742

7.  Multidisciplinary treatment of patients with rectal cancer: Development during the past decades and plans for the future.

Authors:  Bengt Glimelius
Journal:  Ups J Med Sci       Date:  2012-05       Impact factor: 2.384

8.  Type of recurrence is associated with disease-free survival after salvage surgery for locally recurrent rectal cancer.

Authors:  Rosa M Jimenez-Rodriguez; Jonathan B Yuval; Charles-Etienne Gabriel Sauve; Isaac Wasserman; Piyush Aggarwal; Paul B Romesser; Christopher H Crane; Rona Yaeger; Andrea Cercek; Jose G Guillem; Martin R Weiser; Iris H Wei; Maria Widmar; Garrett M Nash; Emmanouil P Pappou; Julio Garcia-Aguilar; Marc J Gollub; Philip B Paty; J Joshua Smith
Journal:  Int J Colorectal Dis       Date:  2021-07-22       Impact factor: 2.796

Review 9.  Surgical treatment of locally recurrent rectal cancer: a narrative review.

Authors:  Zhaoya Gao; Jin Gu
Journal:  Ann Transl Med       Date:  2021-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.